Form 8-K · Current report
Texas Instruments 8-K, filed Jul 22, 2026
- Filed
- CIK
- 0000097476
- Accession no.
- 0000097476-26-000148
Summary
Texas Instruments reported second-quarter 2026 revenue of $5.46 billion, net income of $1.98 billion and earnings per share of $2.14, up 23% in revenue from the same quarter a year earlier, with broad growth led by industrial, data center and automotive. Chairman, president and CEO Haviv Ilan said the company's third-quarter outlook is for revenue of $5.65 billion to $6.15 billion and earnings per share of $2.23 to $2.57.
Key points
- Second-quarter 2026 revenue rose 23% from a year earlier to $5.46 billion, with growth described as broad and led by industrial, data center and automotive markets.
- Net income was $1.98 billion, or $2.14 per diluted share, including a 5-cent benefit that was not in the company's original guidance.
- Trailing-12-month cash flow from operations was $8.7 billion and free cash flow was $6.5 billion; $5.8 billion was returned to shareholders over that period.
- Third-quarter outlook is revenue of $5.65 billion to $6.15 billion and earnings per share of $2.23 to $2.57.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 9.01Financial Statements and Exhibits
From the filing
ITEM 2.02. Results of Operations and Financial Condition The Registrant’s news release dated July 22, 2026, regarding its second-quarter results of operations and financial condition is attached hereto as Exhibit 99. The attached news release includes references to the following financial measures that were not prepared in accordance with generally accepted accounting principles in the United States (non-GAAP measures): free cash flow and ratios based on free cash flow. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.